Debra Ehrlich

874 total citations
22 papers, 353 citations indexed

About

Debra Ehrlich is a scholar working on Neurology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Debra Ehrlich has authored 22 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Debra Ehrlich's work include Neurological disorders and treatments (11 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Debra Ehrlich is often cited by papers focused on Neurological disorders and treatments (11 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Debra Ehrlich collaborates with scholars based in United States and Chile. Debra Ehrlich's co-authors include Mark Hallett, Ruth H. Walker, John D. Heiss, Russell R. Lonser, Krystof S. Bankiewicz, Codrin Lungu, Kareem A. Zaghloul, Tianxia Wu, Stella Elkabes and Dima A. Hammoud and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

Debra Ehrlich

21 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra Ehrlich United States 11 172 148 109 58 49 22 353
Anne Koy Germany 14 299 1.7× 105 0.7× 114 1.0× 34 0.6× 59 1.2× 40 535
Mika H. Martikainen Finland 13 130 0.8× 95 0.6× 205 1.9× 61 1.1× 47 1.0× 34 418
Sarah Camargos Brazil 14 452 2.6× 269 1.8× 167 1.5× 72 1.2× 75 1.5× 51 712
Elisabetta Indelicato Austria 12 161 0.9× 221 1.5× 202 1.9× 16 0.3× 71 1.4× 40 397
Lumine Matsumoto Japan 5 152 0.9× 130 0.9× 206 1.9× 36 0.6× 84 1.7× 6 373
Aleksandra Glavaski‐Joksimovic United States 12 115 0.7× 153 1.0× 125 1.1× 64 1.1× 29 0.6× 16 488
Viorica Chelban United Kingdom 13 185 1.1× 162 1.1× 128 1.2× 41 0.7× 45 0.9× 27 381
Elisabeth Dirren Switzerland 10 90 0.5× 102 0.7× 112 1.0× 24 0.4× 42 0.9× 16 312
Elisa Ferrer Spain 9 159 0.9× 141 1.0× 111 1.0× 60 1.0× 13 0.3× 20 430
Alexandra Guevara Ecuador 10 134 0.8× 48 0.3× 118 1.1× 47 0.8× 29 0.6× 21 352

Countries citing papers authored by Debra Ehrlich

Since Specialization
Citations

This map shows the geographic impact of Debra Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Ehrlich more than expected).

Fields of papers citing papers by Debra Ehrlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Ehrlich. The network helps show where Debra Ehrlich may publish in the future.

Co-authorship network of co-authors of Debra Ehrlich

This figure shows the co-authorship network connecting the top 25 collaborators of Debra Ehrlich. A scholar is included among the top collaborators of Debra Ehrlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra Ehrlich. Debra Ehrlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heiss, John D., Abhik Ray‐Chaudhury, David E. Kleiner, et al.. (2024). Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2‐GDNF in a Patient with Parkinson's Disease. Movement Disorders. 39(8). 1412–1417. 10 indexed citations
2.
Chen, Kong Y., Stephanie T. Chung, Amber B. Courville, et al.. (2024). A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's disease. BMC Neurology. 24(1). 106–106. 14 indexed citations
3.
Vial, Felipe, Patrick McGurrin, Debra Ehrlich, et al.. (2023). Electrophysiological Characterization of a MYH7 Variant with Tremor Phenotype. Movement Disorders Clinical Practice. 10(4). 646–651. 2 indexed citations
4.
Ahmed, Sarah, Ryan Li, Sara Bandrés‐Ciga, et al.. (2023). Association of polygenic risk score with response to deep brain stimulation in Parkinson’s disease. BMC Neurology. 23(1). 143–143. 2 indexed citations
5.
Ehrlich, Debra, Codrin Lungu, Russell R. Lonser, et al.. (2022). Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson’s disease. Molecular Therapy. 30(12). 3632–3638. 31 indexed citations
6.
Lopez, Grisel, et al.. (2022). Imaging and genetics in Parkinson’s disease: assessment of the GBA1 mutation. Journal of Neurology. 269(10). 5347–5355. 4 indexed citations
7.
Zhu, William, Xiaoping Huang, Sara Bandrés‐Ciga, et al.. (2021). Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s disease. Brain. 145(6). 2077–2091. 31 indexed citations
8.
Hallett, Mark, et al.. (2021). Nutritional Ketosis in Parkinson's Disease — a Review of Remaining Questions and Insights. Neurotherapeutics. 18(3). 1637–1649. 20 indexed citations
9.
Hallett, Mark, et al.. (2021). Correction to: Nutritional Ketosis in Parkinson's Disease — a Review of Remaining Questions and Insights. Neurotherapeutics. 18(3). 2133–2133.
10.
McGurrin, Patrick, Felipe Vial, Gina Norato, et al.. (2021). Physiology of Tremor Reduction by Putting the Hands Together in Essential Tremor. Movement Disorders Clinical Practice. 9(2). 191–197. 1 indexed citations
12.
Akano, Emmanuel, Fadar Oliver Otite, Bennett Lavenstein, & Debra Ehrlich. (2019). Indications, Outcomes and Cost of pediatric Deep Brain Stimulation Surgeries in the United States: An Analysis of the Kids’ Inpatient Sample (P4.8-021). Neurology. 92(15_supplement). 1 indexed citations
13.
Vial, Felipe, et al.. (2019). Tremoroton, a new free online platform for tremor analysis. Clinical Neurophysiology Practice. 5. 30–34. 2 indexed citations
14.
Heiss, John D., Codrin Lungu, Dima A. Hammoud, et al.. (2019). Trial of magnetic resonance–guided putaminal gene therapy for advanced Parkinson's disease. Movement Disorders. 34(7). 1073–1078. 84 indexed citations
15.
Narendra, Derek P., Risa Isonaka, Diana Nguyen, et al.. (2019). Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss. Neurology. 92(23). 1113–1115. 9 indexed citations
16.
Ehrlich, Debra & Ruth H. Walker. (2017). Functional neuroimaging and chorea: a systematic review. SHILAP Revista de lepidopterología. 4(1). 8–8. 25 indexed citations
17.
Ehrlich, Debra & Steven J. Frucht. (2016). The phenomenology and treatment of idiopathic adult-onset truncal dystonia: a retrospective review. PubMed. 3(1). 15–15. 7 indexed citations
18.
Ehrlich, Debra, Bo Wang, Wei Lü, Peter C. Dowling, & Ruirong Yuan. (2014). Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma. Journal of Hematology & Oncology. 7(1). 91–91. 21 indexed citations
19.
Kurnellas, Michael, et al.. (2006). Molecular alterations in the cerebellum of the plasma membrane calcium ATPase 2 (PMCA2)-null mouse indicate abnormalities in Purkinje neurons. Molecular and Cellular Neuroscience. 34(2). 178–188. 43 indexed citations
20.
Ehrlich, Debra, et al.. (1982). [Spirometric lung function].. PubMed. 102(5). 191–4. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026